These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 34337994

  • 21. The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVD.
    Agboola F, Lin GA, Kazi DS, McKenna A, Pearson SD.
    J Manag Care Spec Pharm; 2021 Jul; 27(7):961-966. PubMed ID: 34185561
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States.
    Carlson JJ, Guzauskas GF, Chapman RH, Synnott PG, Liu S, Russo ET, Pearson SD, Brouwer ED, Ollendorf DA.
    J Manag Care Spec Pharm; 2018 Jan; 24(1):29-38. PubMed ID: 29290170
    [Abstract] [Full Text] [Related]

  • 23. The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
    Nikitin D, Makam AN, Suh K, McKenna A, Carlson JJ, Richardson M, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2023 Feb; 29(2):216-221. PubMed ID: 36705279
    [Abstract] [Full Text] [Related]

  • 24. The effectiveness and value of novel treatments for cystic fibrosis.
    Tice JA, Kuntz KM, Wherry K, Seidner M, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2021 Feb; 27(2):276-280. PubMed ID: 33506736
    [Abstract] [Full Text] [Related]

  • 25. Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.
    Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.
    J Manag Care Spec Pharm; 2019 Jan; 25(1):80-87. PubMed ID: 30589626
    [Abstract] [Full Text] [Related]

  • 26. The effectiveness and value of novel acute treatments for migraine.
    Agboola F, Atlas SJ, Touchette DR, Borrelli EP, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1456-1462. PubMed ID: 33119447
    [Abstract] [Full Text] [Related]

  • 27. The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.
    Agboola F, Atlas SJ, Touchette DR, Fazioli K, Pearson SD.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):16-20. PubMed ID: 31880219
    [Abstract] [Full Text] [Related]

  • 28. The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy.
    Agboola F, Lin GA, Fluetsch N, Walton SM, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2020 Apr; 26(4):361-366. PubMed ID: 32223597
    [Abstract] [Full Text] [Related]

  • 29. The Effectiveness and Value of Treatments for Spinal Muscular Atrophy.
    Pearson SD, Thokala P, Stevenson M, Rind D.
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1300-1306. PubMed ID: 31778620
    [Abstract] [Full Text] [Related]

  • 30. The Effectiveness and Value of Lanadelumab and C1 Esterase Inhibitors for Prophylaxis of Hereditary Angioedema Attacks.
    Agboola F, Lubinga S, Carlson J, Lin GA, Dreitlein WB, Pearson SD.
    J Manag Care Spec Pharm; 2019 Feb; 25(2):143-148. PubMed ID: 30698087
    [Abstract] [Full Text] [Related]

  • 31. The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy.
    Tice JA, Guzauskas GF, Hansen RN, Herron-Smith S, Segel C, Walsh JME, Pearson SD.
    J Manag Care Spec Pharm; 2020 May; 26(5):620-623. PubMed ID: 32347174
    [Abstract] [Full Text] [Related]

  • 32. The Authors Respond: Reframing the Value of Treatments for Relapsed Refractory Multiple Myeloma.
    Carlson JJ, Guzauskas GF, Chapman RH, Synnott PG, Liu S, Russo ET, Pearson SD, Brouwer ED, Ollendorf DA.
    J Manag Care Spec Pharm; 2018 Jul; 24(7):712-713. PubMed ID: 29952702
    [Abstract] [Full Text] [Related]

  • 33. Can We Develop Sustainable and Sharable Cost-Effectiveness Models for Value Assessment in the U.S. Health Care System?
    Chapman RH, Kumar V.
    J Manag Care Spec Pharm; 2019 May; 25(5):521-524. PubMed ID: 31039064
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin Amyloidosis.
    Mickle K, Lasser KE, Hoch JS, Cipriano LE, Dreitlein WB, Pearson SD.
    J Manag Care Spec Pharm; 2019 Jan; 25(1):10-15. PubMed ID: 30589627
    [Abstract] [Full Text] [Related]

  • 36. The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.
    Tice JA, Campbell JD, Synnott PG, Walsh JME, Kumar VM, Whittington M, Adair E, Rind D, Pearson SD.
    J Manag Care Spec Pharm; 2019 May; 25(5):510-514. PubMed ID: 31039065
    [Abstract] [Full Text] [Related]

  • 37. Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects.
    Smith MR, Sandhu S, George DJ, Chi KN, Saad F, Thiery-Vuillemin A, Stàhl O, Olmos D, Danila DC, Gafanov R, Castro E, Moon H, Joshua AM, Mason GE, Espina BM, Liu Y, Lopez-Gitlitz A, Francis P, Bevans KB, Fizazi K.
    J Manag Care Spec Pharm; 2023 Jul; 29(7):758-768. PubMed ID: 37404070
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany.
    Sardesai A, Dignass A, Quon P, Milev S, Cappelleri JC, Kisser A, Modesto I, Sharma PP.
    J Med Econ; 2021 Jul; 24(1):279-290. PubMed ID: 33502905
    [Abstract] [Full Text] [Related]

  • 39. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.
    Fendrick AM, Brixner D, Rubin DT, Mease P, Liu H, Davis M, Mittal M.
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252
    [Abstract] [Full Text] [Related]

  • 40. A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
    Otuonye IS, Banken R, Kumar VM, Pearson SD.
    J Manag Care Spec Pharm; 2019 Jun; 25(6):630-634. PubMed ID: 31134864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.